Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
8.20
0.00 (0.00%)
At close: Jan 22, 2025, 4:00 PM
8.55
+0.35 (4.27%)
After-hours: Jan 22, 2025, 6:50 PM EST
Cogent Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 906 | 506 | 808 | 342 | 350 | - | |
| Market Cap Growth | 41.86% | -37.32% | 136.30% | -2.42% | - | - | |
| Enterprise Value | 583 | 273 | 605 | 228 | 365 | - | |
| Last Close Price | 8.20 | 5.88 | 11.56 | 8.58 | 11.23 | - | |
| PS Ratio | - | - | - | - | 44.52 | - | |
| PB Ratio | 4.44 | 1.96 | 3.16 | 1.60 | 1.49 | - | |
| P/TBV Ratio | 5.79 | 2.56 | 4.25 | 2.66 | 2.83 | - | |
| EV/Sales Ratio | - | - | - | - | 46.36 | - | |
| Debt / Equity Ratio | 0.06 | 0.07 | 0.08 | 0.01 | 0.02 | 0.19 | |
| Asset Turnover | - | - | - | - | 0.05 | - | |
| Quick Ratio | 6.32 | 6.96 | 9.66 | 12.86 | 18.50 | 2.98 | |
| Current Ratio | 6.44 | 7.09 | 9.87 | 13.04 | 18.70 | 3.06 | |
| Return on Equity (ROE) | -78.47% | -74.94% | -59.69% | -32.20% | -56.16% | - | |
| Return on Assets (ROA) | -44.02% | -42.35% | -34.68% | -19.55% | -14.69% | - | |
| Return on Capital (ROIC) | -49.73% | -47.13% | -37.51% | -20.66% | -15.89% | - | |
| Earnings Yield | -26.60% | -37.99% | -17.36% | -21.14% | -21.35% | - | |
| FCF Yield | -21.09% | -30.89% | -15.53% | -17.69% | -10.23% | - | |
| Buyback Yield / Dilution | -29.32% | -35.61% | -51.66% | -249.52% | -45.42% | - | |
| Total Shareholder Return | -29.32% | -35.61% | -51.66% | -249.52% | -45.42% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.